Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study

被引:35
|
作者
Sorrig, Rasmus [1 ,2 ]
Klausen, Tobias W. [3 ]
Salomo, Morten [1 ]
Vangsted, Annette [1 ,2 ]
Gimsing, Peter [1 ]
机构
[1] Rigshosp, Dept Hematol, Copenhagen, Denmark
[2] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[3] Herlev Hosp, Hematol Res Lab, Herlev, Denmark
关键词
immunoparesis; infection; multiple myeloma; risk factors; STEM-CELL TRANSPLANTATION; T-REGULATORY CELLS; HIGH-DOSE THERAPY; IMMUNE STATUS; EARLY DEATH; MORBIDITY; MORTALITY;
D O I
10.1111/ejh.13190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Infections pose the greatest risk of early death in patients with Multiple Myeloma. However, few studies have analyzed the risk factors for infections in Multiple Myeloma patients. The aim of this study was to analyze the risk factors infections within a population-based MM cohort. Methods Using Danish registries (from 2005 to 2013), we analyzed all ICD-10 codes for infections within the first 6 months of Multiple Myeloma diagnosis in 2557 patients. Results Pneumonia and sepsis represented 46% of infections. Multivariable regression analysis showed that risk factors for pneumonia were male gender (HR 1.4; P = 0.001), ISS II (HR 1.6; P = 0.0004) and ISSIII (HR 1.8; P = 0.0004) and elevated LDH (HR 2.6; P = 0.0008). Risk factors for sepsis were high bone marrow plasma cell % (HR 1.1; P = 0.038), ISS II (HR 1.7; P = 0.007) ISS III (HR 2.0; P = 0.002) and creatinine (HR 2.1; P = 0.002). Neither immunoparesis (hypogammaglobulinemia) nor comorbidity was significant risk factors. Conclusions Our study suggests that tumor burden and renal impairment are risk factors for pneumonia and sepsis in the early phase of Multiple Myeloma.
引用
收藏
页码:182 / 190
页数:9
相关论文
共 50 条
  • [31] Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma
    Tsai, Chun-Kuang
    Yeh, Chiu-Mei
    Hsu, Te-Lin
    Li, Chia-Ju
    Tin, Chian
    Hsiao, Liang-Tsai
    Liu, Yao-Chung
    Wang, Hao-Yuan
    Ko, Po-Shen
    Chen, Po-Min
    Liu, Jin-Hwang
    Gau, Jyh-Pyng
    Liu, Chia-Jen
    SUPPORTIVE CARE IN CANCER, 2021, 29 (07) : 3991 - 3999
  • [32] Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study
    Fan, Huishou
    Wang, Weida
    Zhang, Ya
    Wang, Jianxiang
    Cheng, Tao
    Qiu, Lugui
    Wang, Xin
    Xia, Zhongjun
    An, Gang
    CANCER BIOLOGY & MEDICINE, 2023, 20 (01) : 77 - 87
  • [33] Daratumumab-based regimen for newly diagnosed multiple myeloma patients with paraskeletal plasmacytomas: a retrospective study in a single center
    Xu, Shuiqing
    Chen, Wenming
    Li, Yanchen
    HEMATOLOGY, 2024, 29 (01)
  • [34] Risk factors for blood stream infections in multiple myeloma: A population-based study of 1154 patients in Denmark
    Sorrig, Rasmus
    Klausen, Tobias W.
    Salomo, Morten
    Vangsted, Annette
    Gimsing, Peter
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (01) : 21 - 27
  • [35] Infectious complications in patients with newly diagnosed multiple myeloma: A complication from the past?
    de la Rubia, Javier
    Cejalvo, Maria J.
    Ribas, Paz
    LEUKEMIA & LYMPHOMA, 2016, 57 (02) : 258 - 268
  • [36] Herpes zoster prophylaxis: Essential for treating newly diagnosed multiple myeloma patients
    Lin, Wen-Ying
    Tsai, Chun-Kuang
    Yeh, Chiu-Mei
    Chian, Tin
    Liu, Yao-Chung
    Wang, Hao-Yuan
    Ko, Po-Shen
    Lin, Ting-An
    Hsiao, Liang-Tsai
    Chen, Po-Min
    Gau, Jyh-Pyng
    Liu, Chia-Jen
    CANCER MEDICINE, 2023, 12 (03): : 3013 - 3026
  • [37] Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study
    Ege, Hilmi
    Gertz, Morie A.
    Markovic, Svetomir N.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Kumar, Shaji K.
    Porrata, Luis F.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (06) : 792 - 798
  • [38] A retrospective analysis of cytogenetic alterations in patients with newly diagnosed multiple myeloma: a single center study in Korea
    Li, Shuhua
    Lim, Hyeon-Ho
    Woo, Kwang-Sook
    Kim, Sung-Hyun
    Han, Jin-Yeong
    BLOOD RESEARCH, 2016, 51 (02) : 122 - 126
  • [39] Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas
    Stork, Martin
    Sevcikova, Sabina
    Jelinek, Tomas
    Minarik, Jiri
    Radocha, Jakub
    Pika, Tomas
    Pospisilova, Lenka
    Spicka, Ivan
    Straub, Jan
    Pavlicek, Petr
    Jungova, Alexandra
    Knechtova, Zdenka
    Sandecka, Viera
    Maisnar, Vladimir
    Hajek, Roman
    Pour, Ludek
    BIOMEDICINES, 2022, 10 (10)
  • [40] Survival trends and prognostic factors of patients with newly diagnosed multiple myeloma accompanied with extramedullary disease
    Wang, Jing
    Shen, Na
    Shen, Xuxing
    Zhang, Run
    Jin, Yuanyuan
    Li, Jianyong
    Chen, Lijuan
    ANNALS OF MEDICINE, 2023, 55 (02)